NEW YORK, Sept 19 – Spotfire, a developer of analytics software used by pharmaceutical and biotechnology companies, is considering an initial public offering on the Nasdaq next year.

Chris Ahlberg, Spotfire’s CEO, said the Cambridge, Mass.-based company expects to use money from an IPO for general business purposes. He declined to say how much the company hopes to raise.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.